Clinical Mass Spectrometry in Heart Disease
Department of Cardiovascular Sciences and NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom
*
Author to whom correspondence should be addressed.
Cardiogenetics 2015, 5(1), 5459; https://doi.org/10.4081/cardiogenetics.2015.5459
Submission received: 27 July 2015
/
Revised: 14 September 2015
/
Accepted: 22 September 2015
/
Published: 5 November 2015
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
The presence of mass spectrometry (MS) in the clinical setting is not a new feature, with the use of gas chromatography-MS (GC-MS) for toxicology assays reported as far back as the 1970s [...]
Share and Cite
MDPI and ACS Style
Heaney, L.; Suzuki, T. Clinical Mass Spectrometry in Heart Disease. Cardiogenetics 2015, 5, 5459. https://doi.org/10.4081/cardiogenetics.2015.5459
AMA Style
Heaney L, Suzuki T. Clinical Mass Spectrometry in Heart Disease. Cardiogenetics. 2015; 5(1):5459. https://doi.org/10.4081/cardiogenetics.2015.5459
Chicago/Turabian StyleHeaney, Liam, and Toru Suzuki. 2015. "Clinical Mass Spectrometry in Heart Disease" Cardiogenetics 5, no. 1: 5459. https://doi.org/10.4081/cardiogenetics.2015.5459
